Home · Stock · ABT

ABT Abbott Laboratories

Which ETFs hold ABT? Abbott Laboratories is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 31 Aug 2026
HealthcareMedical Devices
$98.49
-24.0% 1y
$81.9752-week range$134.50
Market cap
$168.7B
P/E
31.8
Dividend
2.56%
3-month
+5.6%
CEO
Mr. Robert B. Ford
Revenue · last 3 qtrs (+13.0% YoY)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Provider

Currently Held By

VANGUARD
VOO
Weight in fund0.29%
Shares held46,275,754
Market value$5.11B
View fund →
SMARTSHARES
USF
Smart US 500 ETF
via VOO
Weight in fund0.29%
Shares held—
Market value$3.6M NZD
View fund →
Not held by the selected provider.
last 90 days
No notable insider activity in the last 90 days. Show all 6 trades
Net flow (90d):−$5.3M·5 BUY / 1 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
30 Sep 2026
Patricia Paola Gonzalez
Director / Other
BUYVested (RSU)333$33K30
30 Sep 2026
Nita Ahuja
Director / Other
BUYVested (RSU)318$31K30
30 Sep 2026
Michael F Roman
Director / Other
BUYVested (RSU)381$38K30
30 Sep 2026
John G Stratton
Director / Other
BUYVested (RSU)397$39K30
30 Sep 2026
Kevin T Conroy
Director / Other
BUYVested (RSU)318$31K30
23 Sep 2026
Kevin T Conroy
Director / Other
SELLVested (RSU)52,507$5.5M0
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
0 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
No trades recorded yet.
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds